Prof. Xiaoli Yu 俞晓立
Chief Physician, Professor
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and comprehensive treatment for breast cancer, soft tissue tumors, gastrointestinal tumors, malignant lymphoma, and urinary system tumors.
Dr. Yu holds a medical doctorate and completed training at Duke University Medical Center (2002–2004) and the Italian National Particle Therapy Center (2012). Dr. Yu became a Fellow of the European Society for Radiotherapy and Oncology (ESTRO) in 2011. Research focuses on clinical and translational studies for breast cancer and soft tissue tumors.
Professional roles
- Standing Committee Member, Radiation Oncology Professional Committee, China Anti-Cancer Association
- Member, Breast Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Radiation Oncology Professional Committee, Shanghai Medical Association
- Standing Committee Member, Breast Cancer Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Yu Xiaoli). Papers usually list the name as Xiaoli Yu or Yu X.
Selected publications
88 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Adv Radiat Oncol, 2025 (senior author): Novel Molecular Subtyping Predicts Locoregional Recurrence in Triple-negative Breast Cancer. PubMed 41333181
- Cancer Med, 2024 (senior author): Plateletcrit is predictive of clinical outcome and prognosis for early-stage breast cancer: A retrospective cohort study based on propensity score matching. PubMed 38348939
- Cancer Med, 2022 (senior author): Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery. PubMed 35598318
- Pract Radiat Oncol, 2022 (senior author): Symptoms Related to Brachial Plexus Neuropathy After Supraclavicular Irradiation and Boost in Breast Cancer. PubMed 34450336
- Asia Pac J Clin Oncol, 2021 (senior author): Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breast. PubMed 33079490
- J Exp Clin Cancer Res, 2020 (senior author): CDK4/6 inhibitors: a novel strategy for tumor radiosensitization. PubMed 32933570
- Breast Cancer, 2020 (senior author): Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting. PubMed 31696449
- Int J Radiat Oncol Biol Phys, 2019 (senior author): Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy. PubMed 30439485
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion